Table 3.
Incidence of PEF or PEFpred% decline according to baseline sarcopenia status from 2011 to 2015
No. of cases/total | Model 1 | Model 2 | Model 3 | ||||||
---|---|---|---|---|---|---|---|---|---|
OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | ||||
PEF decline | |||||||||
No sarcopenia | 1053/2299 | Ref | Ref | Ref | |||||
Non-severe sarcopenia | 193/406 | 1.06 (0.86, 1.31) | 0.568 | 0.98 (0.79, 1.22) | 0.846 | 1.04 (0.78, 1.39) | 0.800 | ||
Severe sarcopenia | 65/115 | 1.53 (1.05, 2.23) | 0.028 | 1.32 (0.89, 1.95) | 0.165 | 2.05 (1.30, 3.26) | 0.002 | ||
PEF%pred decline | |||||||||
No sarcopenia | 883/2289 | Ref | Ref | Ref | |||||
Non-severe sarcopenia | 167/406 | 1.11 (0.90, 1.38) | 0.330 | 1.03 (0.83, 1.29) | 0.790 | 0.96 (0.72, 1.28) | 0.759 | ||
Severe sarcopenia | 58/115 | 1.62 (1.11, 2.36) | 0.012 | 1.43 (0.97, 2.11) | 0.070 | 1.83 (1.17, 2.86) | 0.008 |
Model 1, unadjust
Model 2, adjust for age and sex
Model 3, adjust for age, sex, education level, smoking status, drinking status, BMI, marital status, residential area, type of cooking fuels, baseline PEF or PEF%pred, hypertension, diabetes, heart problems, stroke, and kidney disease